Pharmacology, Toxicology and Pharmaceutical Science
Diseases
80%
Antibiotics
63%
Cross-Sectional Study
43%
Cardiovascular Disease
42%
Prevalence
39%
Tocilizumab
28%
Community Acquired Pneumonia
28%
Pseudomonas aeruginosa
28%
Analgesic Agent
28%
Oseltamivir
28%
Multiple Sclerosis
28%
Orphan Drug
28%
Hydroxychloroquine
28%
Malignant Neoplasm
28%
Observational Study
28%
Non-Steroidal Anti-Inflammatory Drug
28%
Piperacillin Plus Tazobactam
28%
Paritaprevir
28%
Warfarin
28%
Medication Error
28%
Insulin Dependent Diabetes Mellitus
28%
Cytomegalovirus
28%
Hepatitis C Virus Genotype 1
28%
Hepatitis C Virus Genotype 4
28%
Carbapenem
28%
Antidepressant
28%
Linezolid
28%
Gram Positive Bacterium
28%
Diabetic Ketoacidosis
28%
Azithromycin
28%
Side Effect
28%
Thrombocytopenia
28%
Antimicrobial Resistance
28%
Sofosbuvir
28%
Vancomycin
28%
Infection
23%
Chloroquine
22%
Antiinfective Agent
21%
Population Study
17%
Tramadol
14%
Hematologic Malignancy
14%
Structure Activity Relationship
14%
Carbapenem Derivative
14%
Clinical Pharmacy
14%
Paracetamol
14%
Diabetes Mellitus
14%
Pandemic
14%
Retrospective Study
12%
Lymphocytopenia
9%
Recurrence Risk
9%
Nursing and Health Professions
Quality of Life
100%
Systematic Review
85%
Health Care Personnel
76%
Apixaban
30%
Propensity Score
30%
Oseltamivir
28%
Institutionalized Population
28%
Tertiary Care Center
28%
Orphan Drug
28%
Antilipemic Agent
28%
Diabetic Ketoacidosis
28%
Long Acting Insulin
28%
Community Acquired Pneumonia
28%
Antimicrobial Stewardship
28%
Sofosbuvir
28%
Paritaprevir
28%
Medication Error
28%
Health Care Utilization
28%
Anticoagulation
28%
Diseases
23%
Malignant Neoplasm
21%
Hyperlipidemia
18%
Hospital Readmission
17%
Warfarin
16%
Diabetes Mellitus
16%
Sample Size
16%
Biomedical Technology Assessment
14%
Insulin Dependent Diabetes Mellitus
14%
Pig Insulin
10%
Insulin Treatment
10%
Practice Guideline
10%
Anticoagulant Agent
9%
Cross-Sectional Study
9%
Quality Control
9%
Economic Evaluation
9%
Health Care Cost
9%
Minority Group
9%
Health Care
9%
Patient Preference
9%
Hemoglobin Blood Level
9%
Alanine Aminotransferase Level
9%
Medline
8%
Cochrane Library
8%
Healthcare System
7%
Patient-Reported Outcome
7%
Cardiovascular Disease
7%
Antiviral Therapy
5%
Hospital Charge
5%
Length of Stay
5%
Internal Consistency
5%
Medicine and Dentistry
COVID-19
42%
Cross Sectional Study
33%
ANCA Associated Vasculitis
28%
Quality of Life
28%
Health Care Utilization
28%
Antidepressant
28%
Oxygen Consumption
28%
Hematologic Malignancy
28%
Allogeneic Stem Cell Transplantation
28%
Carbapenem
28%
Piperacillin/Tazobactam
28%
Superinfection
28%
Tocilizumab
28%
Myeloperoxidase
18%
Granulomatosis with Polyangiitis
14%
Eosinophilic
14%
Vasculitis
14%
Cytomegalovirus
14%
Carbapenem Derivative
14%
Observational Study
14%
Neutrophil Cytoplasmic Antibody
9%
Myeloblastin
9%
Microscopic Polyangiitis
9%
Selection Bias
9%
Physical Activity
9%
Minority Group
9%
Sulfhemoglobinemia
8%
Combination Therapy
8%
Odds Ratio
7%
Dental Practice
5%
Foley Catheter
5%
Tracheostomy
5%